Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis

Zhang, Wen Cai, Shyh-Chang, Ng, Yang, He, Rai, Amit, Umashankar, Shivshankar, Ma, Siming, Soh, Boon Seng, Sun, Li Li +21 more·2012·Cell
DOI 10.1016/j.cell.2011.11.050

Cited by (113)

Items 101–113 of 113

  1. Beyond the Warburg effect: How do cancer cells regulate one-carbon metabolism?
    Rosenzweig, Adam, Blenis, John, Gomes, Ana P. · 2018 · Frontiers in Cell and Developmental Biology
  2. Targeting LKB1 in Cancer – Exposing and Exploiting Vulnerabilities
    Momcilovic, M, Shackelford, D B · 2015 · British Journal of Cancer
  3. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype
    Sun, Woo Young, Kim, Hye Min, Jung, Woo-Hee, Koo, Ja Seung · 2016 · Journal of Translational Medicine
  4. Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth
    Mukha, Dzmitry, Fokra, Mariam, Feldman, Alona, Sarvin, Boris, Sarvin, Nikita, Nevo-Dinur, Keren, Besser, Elazar, Hallo, Elior, Aizenshtein, Elina, Schug, Zachary T. et al. · 2022 · Cell Metabolism
  5. mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis
    Liu, Rui, Zeng, Lin-Wen, Gong, Rong, Yuan, Fanen, Shu, Hong-Bing, Li, Shu · 2021 · Nature Communications
  6. mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
    Liang, Shun-Qing, Bührer, Elias D., Berezowska, Sabina, Marti, Thomas M., Xu, Duo, Froment, Laurène, Yang, Haitang, Hall, Sean R. R., Vassella, Erik, Yang, Zhang et al. · 2019 · Oncogene
  7. Circumventing senescence is associated with stem cell properties and metformin sensitivity
    Deschênes‐Simard, Xavier, Parisotto, Maxime, Rowell, Marie‐Camille, Le Calvé, Benjamin, Igelmann, Sebastian, Moineau‐Vallée, Karine, Saint‐Germain, Emmanuelle, Kalegari, Paloma, Bourdeau, Véronique, Kottakis, Filippos et al. · 2019 · Aging Cell
  8. Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming
    Paiardini, Alessandro, Tramonti, Angela, Schirch, Doug, Guiducci, Giulia, di Salvo, Martino Luigi, Fiascarelli, Alessio, Giorgi, Alessandra, Maras, Bruno, Cutruzzolà, Francesca, Contestabile, Roberto · 2016 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  9. Cancer proteome and metabolite changes linked to SHMT2
    Tong, Jiefei, Krieger, Jonathan R., Taylor, Paul, Bagshaw, Rick, Kang, Jae, Jeedigunta, Swathi, Wybenga-Groot, Leanne E., Zhang, Wen, Badr, Heba, Mirhadi, Shideh et al. · 2020 · PLoS ONE
  10. Acetylation: a new target for protein degradation in cancer
    Crawford, Callie E.W., Burslem, George M. · 2025 · Trends in Cancer
  11. Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
    Mendes, Cindy, Serpa, Jacinta · 2019 · Antioxidants
  12. Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes
    Tramonti, Angela, Paiardini, Alessandro, Paone, Alessio, Bouzidi, Amani, Giardina, Giorgio, Guiducci, Giulia, Magnifico, Maria Chiara, Rinaldo, Serena, McDermott, Lee, Menendez, Javier A. et al. · 2018 · Archives of Biochemistry and Biophysics
  13. GLDC promotes colorectal cancer metastasis through epithelial–mesenchymal transition mediated by Hippo signaling pathway
    Yu, Hao, Hu, Xueqing, Zhang, Yingru, Wang, Jiajia, Ni, Zhongya, Wang, Yan, Zhu, Huirong · 2023 · Medical Oncology